Performance in clinical research

Clinical trials at The Christie draw patients from the Greater Manchester and Cheshire area.

During 2014, research studies at The Christie recruited 1,815 patients.   

Performance in initiating and delivering clinical research   

The Government's Plan for Growth, published in March 2011, announced the transformation of incentives at local level for efficiency in initiation and delivery of clinical research.  

The National Institute of Health Research (NIHR) has established two performance benchmarks against which we and other NHS providers are measured.  

As a major UK Cancer Research Centre with improvement in patient outcomes our primary aim, we are committed to the principle of initiating studies as efficiently as possible and delivering planned recruitment on time, and therefore we have welcomed these benchmarks.   

The two benchmarks are:  

  • Initiating Clinical Research   - This looks at how quickly studies are set up and recruited to.   
  • Delivering Clinical Research – (AKA time and target) This looks at whether or not we've recruited the target number of patients in the time frame we said we would

The aim here is to increase the number of patients who have the opportunity to participate in research and to enhance the nation's attractiveness as a host for research.

We also host a number of clinical trials in rare diseases or rare sub-types of common diseases, which means it often takes some time to identify and recruit the first patient.   

We are currently required to submit data on these two benchmarks to NIHR on a quarterly basis. Our most recent submission was October 2018 and the submitted data is provided below.   

Initiating Clinical Research

This includes all of our clinical trials we have approved between 01-Oct-2017 and 30-Sep 2018.

Delivering Clinical Research  

This includes all of our commercial clinical trials that have closed to recruitment between 01-Oct-2017 to 30-Sep-2018.



Manchester University Manchester Academic Health Science CentreCancer Research UK National Institute for Health Records